Oklahoma OT Jurisprudence study materials
Oklahoma OT Jurisprudence study resources

Dry Needling, an Axillary Wound, and the Authorization Limit

Oklahoma OT Jurisprudence · Put your knowledge to work in context.

All case studies

Dry Needling, an Axillary Wound, and the Authorization Limit

A 62-year-old woman with breast cancer–related lymphedema is referred by her oncologist with a prescription reading “OT evaluate and treat.” She has a 2 cm superficial wound in the axilla and asks for “dry needling” for axillary web syndrome. The OT has a 16-hour continuing education certificate in dry needling but no other credential or supervision. The clinic’s website says the OT is “certified in dry needling,” although the certificate says “training completed.” The patient’s insurer has authorized 12 visits; 8 are used. The patient asks the OT to continue for 6 more visits and to “work on the scar tissue” in the wound. The OT’s employer says dry needling is “just a modality” and can be billed under the existing authorization. The OT wonders whether to perform dry needling, debride the wound, and how to handle the remaining visits.

1. Analyze whether dry needling and wound debridement are within this OT’s scope and authority.

Read the worked answer

Scope of practice is not established by a continuing education certificate alone. The OT must check the Oklahoma Practice Act, Board rules, and any Board position statement on dry needling. If dry needling is not expressly authorized, or if it requires additional training, supervision, or a specific credential, the 16-hour certificate is not enough. The website claim “certified in dry needling” is also inaccurate if the document only says “training completed”; the OT must correct the marketing.

Sharp debridement of a 2 cm axillary wound is likewise not automatically within OT scope. It may require medical direction, specific wound-care competency, and compliance with facility policy. The OT should not debride the wound based only on the oncologist’s general “evaluate and treat” prescription. The safer course is to coordinate with the oncologist or wound-care team, document the wound status, and provide OT interventions that are within scope, such as edema management, positioning, and activity modification.

2. How should the OT handle informed consent and the patient’s request to continue beyond the authorized visits?

Read the worked answer

The OT must obtain informed consent for each intervention, explaining the expected benefit, risks, alternatives, and the OT’s actual credentials. The patient should be told that dry needling is not being provided if the OT lacks authority, and why. If dry needling is later authorized, the consent must describe the specific technique and the OT’s training.

The insurer has authorized four remaining visits. The OT cannot simply continue for six more visits or bill dry needling under the existing authorization unless the payer rules permit it and the service is covered. The OT should document medical necessity, submit a request for additional visits with objective progress, and explain to the patient that scheduling beyond authorization may create financial responsibility. The OT should not let the employer’s billing instruction override the authorization limits.

3. What documentation and interprofessional steps should the OT take before the next treatment session?

Read the worked answer

The OT should document the referral, the evaluation findings, the wound assessment (without performing debridement), the patient’s goals, and the specific OT interventions planned. The note should state that dry needling was discussed but not performed because scope/credentialing was unresolved. The OT should contact the oncologist about the axillary wound and any dry needling request, and coordinate with wound care or nursing as appropriate.

The OT should also correct the website and any patient-facing materials, verify the payer’s authorization, and obtain informed consent for the interventions actually provided. If the employer insists on billing dry needling under the current authorization, the OT should escalate to compliance and decline to participate in inaccurate billing.